Absence Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in GABRA1, GABRG2, and GABRB3 are associated with absence seizures, while mutations in CLCN2 and myoclonin/EFHC1 substantiate juvenile myoclonic epilepsy as a clinical entity.
|
16302874 |
2005 |
Absence Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The object of this study was to investigate whether or not CAE is associated with the gene encoding the gamma-aminobutyric acid (GABA) type-A receptor subunits alpha5 (GABRA5) and beta3 (GABRB3) in a Chinese population.
|
15498372 |
2004 |
Absence Epilepsy
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|
Absence Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We screened the open reading frame of GABRB3 in 183 French-Canadian individuals with IGE, including 88 with CAE.
|
20550555 |
2010 |
Absence Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in inhibitory GABAA receptor subunit genes (GABRA1, GABRB3, GABRG2 and GABRD) have been associated with genetic epilepsy syndromes including childhood absence epilepsy (CAE), juvenile myoclonic epilepsy (JME), pure febrile seizures (FS), generalized epilepsy with febrile seizures plus (GEFS+), and Dravet syndrome (DS)/severe myoclonic epilepsy in infancy (SMEI).
|
20308251 |
2010 |
Absence Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The object of the present study was to test association between CAE and the genes encoding the gamma-aminobutyric acid (GABA) type-A receptor subunits alpha 5 (GABRA5) and beta 3 (GABRB3) located on the long arm of chromosome 15 (15q11-q13).
|
10509183 |
1999 |
Depressive disorder
|
0.430 |
Biomarker
|
disease |
HPO |
|
|
|
Depressive disorder
|
0.430 |
Biomarker
|
disease |
BEFREE |
Patients carrying the GABRB3 G1+ allele showed stronger AE relating to negative affective change (for example, increased depression) than their GABRB3 G1- counterparts.
|
15296817 |
2004 |
Depressive disorder
|
0.430 |
Biomarker
|
disease |
PSYGENET |
Recently, microsatellite polymorphisms have been reported to be associated with four genes, GABRB3, MAOB, PAH, and SLC6A4, and their relationships have been tested to five symptom factors: hallucinations, delusions, negative symptoms, mania, and depression.
|
22414661 |
2012 |
Depressive disorder
|
0.430 |
GeneticVariation
|
disease |
BEFREE |
The rs4906902 G allele of the GABRB3 gene was overrepresented in mTLE patients with depression; individuals homozygous for the G allele showed reduced GABRB3 mRNA expression.
|
22082659 |
2011 |
Depressive disorder
|
0.430 |
Biomarker
|
disease |
PSYGENET |
The rs4906902 G allele of the GABRB3 gene was overrepresented in mTLE patients with depression; individuals homozygous for the G allele showed reduced GABRB3 mRNA expression.
|
22082659 |
2011 |
Depressive disorder
|
0.430 |
Biomarker
|
disease |
PSYGENET |
Patients carrying the GABRB3 G1+ allele showed stronger AE relating to negative affective change (for example, increased depression) than their GABRB3 G1- counterparts.
|
15296817 |
2004 |
Depressive disorder
|
0.430 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, the present study indicates that in a population of PTSD patients, heterozygosity of the GABRB3 major (G1) allele confers higher levels of somatic symptoms, anxiety/insomnia, social dysfunction and depression than found in homozygosity.
|
11711165 |
2001 |
Depressive disorder
|
0.430 |
Biomarker
|
disease |
PSYGENET |
In conclusion, the present study indicates that in a population of PTSD patients, heterozygosity of the GABRB3 major (G1) allele confers higher levels of somatic symptoms, anxiety/insomnia, social dysfunction and depression than found in homozygosity.
|
11711165 |
2001 |
Depressive disorder
|
0.430 |
Biomarker
|
disease |
PSYGENET |
We tested four genes [phenylalanine hydroxylase (PAH), the serotonin transporter (SLC6A4), monoamine oxidase B (MAOB), and the gamma-aminobutyric acid A receptor beta-3 subunit (GABRB3)] for their impact on five schizophrenia symptom factors: delusions, hallucinations, mania, depression, and negative symptoms.
|
19268543 |
2009 |
Autistic Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We have screened the families of the Collaborative Linkage Study of Autism for several markers spanning a candidate region covering approximately 2 Mb and including the Angelman syndrome gene (UBE3A) and a cluster of gamma-aminobutyric acid (GABA(A)) receptor subunit genes (GABRB3, GABRA5, and GABRG3).
|
11543639 |
2001 |
Autistic Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Additionally, 15q11-q13 in the region of GABRB3 holds interest as a potential site of a susceptibility gene for autism.
|
10374739 |
1999 |
Autistic Disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
Examining paternal transmissions only, we found marginal evidence for LD with a protective allele at marker D15S11 in the ASD families (Chi-sq 7 df, P = 0.05) and marginal evidence for risk alleles at markers D15S1506 (Chi-sq 13.7, 6 df, P = 0.06), GABRB3 (Chi-sq 15.9, 8 df, P = 0.11) and D15S1002 (Chi-sq 17.7, 9 df, P = 0.08) in the autism only families.
|
15952184 |
2005 |
Autistic Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
One 15q11-q13 locus encodes the GABA(A) receptor β3 subunit gene (GABRB3), which has been implicated by several studies in both autism and absence epilepsy, and the co-morbidity of epilepsy in autism is well established.
|
19935738 |
2011 |
Autistic Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Further analysis indicated that no associations were found between GABRB3 SNPs and autism on rs2081648 [OR = 0.84 (95% CI) = 0.41-1.72, I<sup>2</sup> = 89.2%] and rs1426217 [OR = 1.13 (95% CI) = 0.64-2.0, I<sup>2</sup> = 83%].
|
29725984 |
2018 |
Autistic Disorder
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
The association and linkage study for the gamma-aminobutyric acid type A receptor beta3 subunit gene (GABRB3), located within the chromosome 15q11-q13 autism candidate region, and ASD have been evaluated.
|
17230033 |
2006 |
Autistic Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Association between a GABRB3 polymorphism and autism.
|
11920158 |
2002 |
Autistic Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in GABRB3 have frequently been associated with epilepsy and autism, consistent with its role in neurodevelopment.
|
28009282 |
2016 |
Autistic Disorder
|
0.400 |
Biomarker
|
disease |
CTD_human |
The convergence of GABRB3 as a positional and functional candidate along with the linkage-disequilibrium data suggests the need for further investigation of the role of GABRB3 or adjacent genes in autistic disorder.
|
9545402 |
1998 |
Autistic Disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
The convergence of GABRB3 as a positional and functional candidate along with the linkage-disequilibrium data suggests the need for further investigation of the role of GABRB3 or adjacent genes in autistic disorder.
|
9545402 |
1998 |